具核梭杆菌对结直肠癌细胞增殖、迁移及上皮间质转化作用的影响
作者:
基金项目:

辽宁省自然科学基金民族创新联合基金(2020-MZLH-07)


Effect of Fusobacterium nucleatum on proliferation, migration and epithelial-to-mesenchymal transition of colorectal cancer cells
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [21]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    【目的】评估具核梭杆菌对人结直肠癌细胞HCT116和人正常结肠上皮细胞HCoEpiC的增殖、黏附、凋亡、迁移、侵袭和上皮间质转化的影响。【方法】本研究用不同感染复数(MOI)Fusobacterium nucleatum ATCC 23726感染人结直肠癌细胞HCT116和人正常结肠上皮细胞HCoEpiC,建立感染模型;用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,MTT]、平板克隆、细胞划痕及侵袭(transwell)实验检测两组细胞的增殖、迁移和侵袭的变化;用流式细胞仪检测两组细胞凋亡情况;通过Western blotting检测两组细胞上皮标记物上皮细胞钙黏蛋白(E-cadherin)、Catenin δ-1蛋白、间充质标记物N-钙粘蛋白(N-cadherin)和波形蛋白(vimentin)表达水平的变化。【结果】F.nucleatum可促进HCT116细胞增殖,诱导HCT116细胞的迁移和侵袭,但不能引起细胞凋亡;可抑制HCoEpiC细胞的增殖、迁移和侵袭,并加速其凋亡;对HCT116和HCoEpiC细胞表现出很强的粘附能力,致细胞分散和拉长,细胞间粘附减少;使HCT116和HCoEpiC细胞上皮标记物E-cadherin与Catenin δ-1的表达量减少,间充质标记物N-cadherin与vimentin的表达量上升,E-cadherin由细胞膜向细胞质转移。【结论】F.nucleatum可诱导结直肠癌细胞和人正常结肠上皮细胞发生上皮间质转化,但抑制人正常结肠细胞的增殖、迁移和侵袭,表现出与结直肠癌细胞相反的作用。

    Abstract:

    [Objective] This study aims to investigate the effects of Fusobacterium nucleatum on the proliferation, adhesion, apoptosis, migration, invasion, and epithelial-to-mesenchymal transition (EMT) of colorectal cancer cell line HCT116 and human normal colon epithelial cell line HCoEpiC. [Methods] HCT116 and HCoEpiC cells were stimulated with F. nucleatum ATCC 23726 at different multiplicity of infection (MOI) to establish infection models, and then MTT, plate cloning assay, wound healing assay, and transwell assay were employed to measure cell proliferation, migration, and invasion. Flow cytometry was employed to detect cell apoptosis. The expression levels of E-cadherin, catenin δ-1, N-cadherin, and vimentin were determined by Western blotting. [Results] F. nucleatum promoted the proliferation, induced the migration and invasion, and did not induce the apoptosis of HCT116 cells. However, it inhibited the proliferation, migration, and invasion and accelerated the apoptosis of HCoEpiC cells. F. nucleatum exhibited strong adhesion to HCT116 and HCoEpiC cells, resulting in dispersed and elongated cells and reduced intercellular adhesion. This bacterium down-regulated the expression levels of the epithelial markers E-cadherin and catenin δ-1 and up-regulated those of the mesenchymal markers N-cadherin and vimentin in HCT116 and HCoEpiC cells. In addition, it promoted the transition of E-cadherin from the cell membrane to the cytoplasm. [Conclusion] F. nucleatum can adhere to both normal colon epithelial cells and colon cancer cells and induce EMT. However, it inhibited the proliferation, migration, and invasion of human normal colon epithelial cells, showing the effect opposite to that on colon cancer cells.

    参考文献
    [1] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020. CA: A Cancer Journal for Clinicians, 2021, 71(3):209-249.
    [2] Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018. CA: A Cancer Journal for Clinicians, 2018, 68(6):394-424.
    [3] Hampel H, Kalady MF, Pearlman R, Stanich PP. Hereditary colorectal cancer. Hematology/Oncology Clinics of North America, 2022, 36(3):429-447.
    [4] Vernia F, Longo S, Stefanelli G, Viscido A, Latella G. Dietary factors modulating colorectal carcinogenesis. Nutrients, 2021, 13(1):143.
    [5] Osman MA, Neoh HM, Ab Mutalib NS, Chin SF, Mazlan L, Raja Ali RA, Zakaria AD, Ngiu CS, Ang MY, Jamal R. Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer. Scientific Reports, 2021, 11:2925.
    [6] McIlvanna E, Linden GJ, Craig SG, Lundy FT, James JA. Fusobacterium nucleatum and oral cancer:a critical review. BMC Cancer, 2021, 21(1):1212.
    [7] Wong SH, Yu J. Gut microbiota in colorectal cancer:mechanisms of action and clinical applications. Nature Reviews Gastroenterology & Hepatology, 2019, 16(11):690-704.
    [8] Chen SJ, Su TT, Zhang Y, Lee A, He JM, Ge QW, Wang L, Si JM, Zhuo W, Wang LJ. Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7. Gut Microbes, 2020, 11(3):511-525.
    [9] Yu T, Guo FF, Yu YN, Sun TT, Ma D, Han JX, Qian Y, Kryczek I, Sun DF, Nagarsheth N, Chen YX, Chen HY, Hong J, Zou WP, Fang JY. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell, 2017, 170(3):548-563.e16.
    [10] Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research, 2012, 22(2):299-306.
    [11] Komiya Y, Shimomura Y, Higurashi T, Sugi Y, Arimoto J, Umezawa S, Uchiyama S, Matsumoto M, Nakajima A. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity. Gut, 2019, 68(7):1335-1337.
    [12] Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song MY, da Silva A, Gu MC, Li WW, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino S. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clinical and Translational Gastroenterology, 2016, 7(11):e200.
    [13] Yang YZ, Weng WH, Peng JJ, Hong LM, Yang L, Toiyama Y, Gao RY, Liu MF, Yin MM, Pan C, Li H, Guo BM, Zhu QC, Wei Q, Moyer MP, Wang P, Cai SJ, Goel A, Ma YL. Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor-κB, and up-regulating expression of microRNA-21. Gastroenterology, 2017, 152(4):851-866.e24.
    [14] Peng C, Ouyang YB, Lu NH, Li NS. The NF-κB signaling pathway, the microbiota, and gastrointestinal tumorigenesis:recent advances. Frontiers in Immunology, 2020, 11:1387.
    [15] Sahan AZ, Hazra TK, Das S. The pivotal role of DNA repair in infection mediated-inflammation and cancer. Frontiers in Microbiology, 2018, 9:663.
    [16] Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multi species biofilm development and the key role of cell-cell distance. Nature Reviews Microbiology, 2010, 8(7):471-480.
    [17] Gao ZG, Guo BM, Gao RY, Zhu QC, Wu W, Qin HL. Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer. Molecular Medicine Reports, 2015, 12(4):6119-6127.
    [18] Brennan CA, Garrett WS. Fusobacterium nucleatum— symbiont, opportunist and oncobacterium. Nature Reviews Microbiology, 2019, 17(3):156-166.
    [19] Engevik MA, Danhof HA, Ruan W, Engevik AC, Chang-Graham AL, Engevik KA, Shi ZC, Zhao YL, Brand CK, Krystofiak ES, Venable S, Liu XL, Hirschi KD, Hyser JM, Spinler JK, Britton RA, Versalovic J. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio, 2021, 12(2):e02706-e02720.
    [20] Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang XY, Cai DA, Neuberg D, Huang K, Guevara F, Nelson T, Chipashvili O, Hagan T, Walker M, Ramachandran A, Diosdado B, Serna G, Mulet N, Landolfi S, Cajal SRY, Fasani R, Aguirre AJ, Ng K, Élez E, Ogino S, Tabernero J, Fuchs CS, Hahn WC, Nuciforo P, Meyerson M. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science, 2017, 358(6369):1443-1448.
    [21] Yu MR, Kim HJ, Park HR. Fusobacterium nucleatum accelerates the progression of colitis-associated colorectal cancer by promoting EMT. Cancers, 2020, 12(10):2728.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

张旭强,郭斌梅,陈苛蒙,李竺婷,范若辰,金黎明,王豫鑫,权春善. 具核梭杆菌对结直肠癌细胞增殖、迁移及上皮间质转化作用的影响[J]. 微生物学报, 2022, 62(12): 4841-4853

复制
分享
文章指标
  • 点击次数:348
  • 下载次数: 907
  • HTML阅读次数: 1188
  • 引用次数: 0
历史
  • 收稿日期:2022-03-27
  • 最后修改日期:2022-06-21
  • 在线发布日期: 2022-12-08
文章二维码